Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Metrics to compare | HSDT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHSDTPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.3x | −3.9x | −0.6x | |
PEG Ratio | - | −0.19 | 0.00 | |
Price/Book | 1.1x | 2.8x | 2.6x | |
Price / LTM Sales | 22.8x | 3.7x | 3.3x | |
Upside (Analyst Target) | - | 25.4% | 37.4% | |
Fair Value Upside | Unlock | 7.3% | 4.5% | Unlock |